Literature DB >> 20658592

Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization.

Amanda M Brandow, Danielle L Jirovec, Julie A Panepinto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20658592      PMCID： PMC2911651          DOI： 10.1002/ajh.21749

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  27 in total

1.  Transfusion management strategies: a survey of practicing pediatric hematology/oncology specialists.

Authors:  Edward C C Wong; Evelio Perez-Albuerne; Jeffrey A Moscow; Naomi L C Luban
Journal:  Pediatr Blood Cancer       Date:  2005-02       Impact factor: 3.167

2.  Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

Authors:  Jane S Hankins; Russell E Ware; Zora R Rogers; Lynn W Wynn; Peter A Lane; J Paul Scott; Winfred C Wang
Journal:  Blood       Date:  2005-10-01       Impact factor: 22.113

3.  Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.

Authors:  Marc S Zumberg; Suresh Reddy; Robert L Boyette; Robert J Schwartz; Thomas R Konrad; Richard Lottenberg
Journal:  Am J Hematol       Date:  2005-06       Impact factor: 10.047

4.  Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.

Authors:  T R Kinney; R W Helms; E E O'Branski; K Ohene-Frempong; W Wang; C Daeschner; E Vichinsky; R Redding-Lallinger; B Gee; O S Platt; R E Ware
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

5.  Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance.

Authors:  Barbara S Shapiro; David F Dinges; Emily Carota Orne; Nancy Bauer; Linnette B Reilly; Wayne G Whitehouse; Kwaku Ohene-Frempong; Martin T Orne
Journal:  Pain       Date:  1995-04       Impact factor: 6.961

6.  Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.

Authors:  A Ferster; C Vermylen; G Cornu; M Buyse; F Corazza; C Devalck; P Fondu; M Toppet; E Sariban
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

7.  Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia.

Authors:  S Jayabose; O Tugal; C Sandoval; P Patel; D Puder; T Lin; P Visintainer
Journal:  J Pediatr       Date:  1996-10       Impact factor: 4.406

8.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; M L Terrin; R D Moore; G J Dover; F B Barton; S V Eckert; R P McMahon; D R Bonds
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

9.  Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial.

Authors:  Michael R Debaun; Joshua J Field
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

10.  Daily assessment of pain in adults with sickle cell disease.

Authors:  Wally R Smith; Lynne T Penberthy; Viktor E Bovbjerg; Donna K McClish; John D Roberts; Bassam Dahman; Imoigele P Aisiku; James L Levenson; Susan D Roseff
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391
View more
  31 in total

1.  Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease.

Authors:  Amanda M Brandow; Julie A Panepinto
Journal:  Am J Hematol       Date:  2011-08-03       Impact factor: 10.047

2.  Do difficulties in swallowing medication impede the use of hydroxyurea in children?

Authors:  ElShadey Bekele; Courtney D Thornburg; Amanda M Brandow; Mukta Sharma; Arlene M Smaldone; Zhezhen Jin; Nancy S Green
Journal:  Pediatr Blood Cancer       Date:  2014-04-17       Impact factor: 3.167

3.  Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.

Authors:  Kismet Baldwin; Fabrizia Urbinati; Zulema Romero; Beatriz Campo-Fernandez; Michael L Kaufman; Aaron R Cooper; Katelyn Masiuk; Roger P Hollis; Donald B Kohn
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

Review 4.  Medication adherence among pediatric patients with sickle cell disease: a systematic review.

Authors:  Kathleen E Walsh; Sarah L Cutrona; Patricia L Kavanagh; Lori E Crosby; Chris Malone; Katie Lobner; David G Bundy
Journal:  Pediatrics       Date:  2014-11-17       Impact factor: 7.124

5.  Disease severity and slower psychomotor speed in adults with sickle cell disease.

Authors:  Dana R Jorgensen; Andrea Metti; Meryl A Butters; Joseph M Mettenburg; Caterina Rosano; Enrico M Novelli
Journal:  Blood Adv       Date:  2017-09-14

6.  Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.

Authors:  Jason R Hodges; Shannon M Phillips; Sarah Norell; Chinonyelum Nwosu; Hamda Khan; Lingzi Luo; Sherif M Badawy; Allison King; Paula Tanabe; Marsha Treadwell; Lucia Rojas Smith; Cecelia Calhoun; Jane S Hankins; Jerlym Porter
Journal:  Blood Adv       Date:  2020-09-22

7.  A Retrospective Analysis of Sociodemographic and Hematologic Characteristics Associated With Achieving Optimal Hydroxyurea Therapy in Children With Sickle Cell Disease.

Authors:  Paul E George; Juan C Bazo-Alvarez; Vivien A Sheehan
Journal:  J Pediatr Hematol Oncol       Date:  2018-07       Impact factor: 1.289

8.  Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use.

Authors:  Nancy S Green; Deepa Manwani; Mahvish Qureshi; Karen Ireland; Arpan Sinha; Arlene M Smaldone
Journal:  Pediatr Blood Cancer       Date:  2016-08-30       Impact factor: 3.167

9.  National trends in incidence rates of hospitalization for stroke in children with sickle cell disease.

Authors:  Timothy L McCavit; Lei Xuan; Song Zhang; Glenn Flores; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2012-11-14       Impact factor: 3.167

10.  Impact of hydroxyurea on clinical events in the BABY HUG trial.

Authors:  Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.